Purpose: The superior soft tissue contrast of magnetic resonance imaging (MRI) compared to computed tomography (CT) has urged the integration of MRI and elimination of CT in radiotherapy treatment (RT) for prostate. An intraprostatic gold fiducial marker (GFM) appears hyperintense on CT. On T2-weighted (T2w) MRI target delineation images, the GFM appear as a small signal void similar to calcifications and post biopsy fibrosis. It can therefore be difficult to identify the markers without CT. Detectability of GFMs can be improved using additional MR images, which are manually registered to target delineation images. This task requires manual labor, and is associated with interoperator differences and image registration errors. The aim of this work was to develop and evaluate an automatic method for identification of GFMs directly in the target delineation images without the need for image registration. Methods: T2w images, intended for target delineation, and multiecho gradient echo (MEGRE) images intended for GFM identification, were acquired for prostate cancer patients. Signal voids in the target delineation images were identified as GFM candidates. The GFM appeared as round, symmetric, signal void with increasing area for increasing echo time in the MEGRE images. These image features were exploited for automatic identification of GFMs in a MATLAB model using a patient training dataset (n = 20). The model was validated on an independent patient dataset (n = 40). The distances between the identified GFM in the target delineation images and the GFM in CT images were measured. A human observatory study was conducted to validate the use of MEGRE images. Results: The sensitivity, specificity, and accuracy of the automatic method and the observatory study was 84%, 74%, 81% and 98%, 94%, 97%, respectively. The mean absolute difference in the GFM distances for the automatic method and observatory study was 1.28 AE 1.25 mm and 1.14 AE 1.06 mm, respectively. Conclusions: Multiecho gradient echo images were shown to be a feasible and reliable way to perform GFM identification. For clinical practice, visual inspection of the results from the automatic method is needed at the current stage.
INTRODUCTION
Since the introduction of modern radiotherapy treatment planning (RTP), computed tomography (CT) has been the primary imaging modality used for RTP and delineation of target and organs at risk (OAR). A major drawback using CT images for this purpose is the limited soft tissue contrast. Magnetic resonance imaging (MRI) has superior soft tissue 5563 Med. Phys. 44 (11) , November 2017 0094-2405/2017/44(11)/5563/12 contrast compared to CT and a widespread introduction of MRI into the radiotherapy clinics have therefore been seen in recent years. 1, 2 It has also been proved that MRI can add clinical value to the target delineation process in external beam radiation therapy (EBRT), in particular of prostate. 3, 4 Today MRI is mainly used for target delineation in combination with CT. This procedure requires image registration between CT and MRI. Despite the superior contrast of MRI, the CT is helpful to provide the Hounsfield unit (HU) map of the tissues as input for the treatment planning calculations.
In the image registration process, an additional spatial uncertainty can be introduced in the RTP. 5 To avoid this and still profit from the superior soft tissue contrast in MRI, a workflow solely based on MRI (where the CT is excluded) is desired. Such a workflow is referred to as an MRI only workflow. In this workflow, the Hounsfield units of the tissue are calculated from the MR images and the resulting images are referred to as a synthetic CT (sCT). Multiple methods for creating sCT for prostate RTP has been presented. [6] [7] [8] [9] [10] The dosimetric accuracy in high-quality sCTs for prostate cancer RTP is sufficient. 6, 7, [11] [12] [13] The sCTs can also be used as reference images for image-guided RT.
14 Thus, the entire RTP workflow can be conducted with MRI only. 15 At certain clinics, the prostate MRI only workflow has been used for standard clinical practice since 2012. 10, 15 The workflow, however, draws from lack of automatic gold fiducial marker detection.
For standard EBRT of prostate cancer, the ordinated total radiation dose to the prostate is divided into a number of smaller treatment fractions (e.g., 39 fractions over 8 weeks, total dose 78 Gy). A reproducible patient setup for the delivery of each treatment fraction to the prostate is essential. A common method to facilitate such a patient setup is to, prior to the start of the EBRT, insert small cylinder-shaped gold fiducial markers (GFMs) into the prostate. After setup of the patient at the RT table, the GFMs can be visualized using on board image guidance techniques such as x-ray imaging or cone beam CT (CBCT), and the patient position can be adjusted in connection to each treatment fraction. The visualization of the GFMs is straightforward on x-ray, CT, and CBCT as they appear hyperintense. However, x-ray-based images suffer from beam hardening and streak artifacts around GFMs.
In MR images, the GFMs are hypointense as they do not produce any genuine nuclear magnetic resonance signal. 16 The GFMs and the surrounding tissue interact with, and distorts the external static magnetic field in different ways. This can be quantitatively measured and is referred to as magnetic susceptibility. Due to the difference in magnetic susceptibility between GFMs and tissue, the MR signal around the GFMs is degraded. 17, 18 The GFMs are therefore visualized as signal voids with shape and size dependent on the nature of the MRI sequence, the acquisition parameters, and the shape and orientation of the GFMs. 17, 19 Previous studies have investigated different ways of detecting and visualizing a metallic structure within the patient. Both spin echo and gradient echo MRI sequences have been suggested to improve the signal void visibility. [20] [21] [22] [23] [24] [25] [26] Combinations of different MRI sequences has also been suggested. 27, 28 The use of more exotic sequences to even enable a positive contrast of the metal has been developed. [29] [30] [31] [32] The use of multiple dedicated MRI sequences for prostate RTP is common. The proposed MRI only workflows for EBRT of prostate present in the literature all depend on separate MRI sequences for GFM identification, target delineation, and sCT generation. 12, 25, 33, 34 The use of separate sequences is unfavorable due to several reasons. First, multiple sequences increase the examination time. Secondly, there is a risk of patient motion between the image acquisitions which often requires image registration. An MRI sequence that would identify the GFMs, enable sCT generation, and target delineation in one single sequence with reasonable scan time is therefore desirable. To the best of our knowledge, the use of such a sequence has not been presented in the literature. To address the issue above concerning image registration, it would be of benefit to identify the GFMs directly in the image of interest.
T2-weighted (T2w) MRI sequences based on fast spin echo (FSE) are recommended and generally used for visualizing the internal structure of the prostate as the image contrast is sensitive for pathology. 35 With clinically used T2w FSEbased sequences, it has been shown that the delineation of GFMs has a maintained clinical acceptable spatial accuracy and that they are only visualized as small signal voids. 19 This behavior is due to several factors. The transversal orientation of the T2w image and the inferior-superior orientation of the long axis of the cylinder-shaped GFMs expose a cross section of the GFM that is minimal in the transversal imaging plane. Furthermore, the effect of the difference in magnetic susceptibility between the GFMs and the surrounding tissue is mitigated due to the reduction of susceptibility-induced signal losses provided by the FSE technique.
Intraprostatic calcifications of > 2 mm in diameter are estimated to exist in one-third of the patients undergoing EBRT of prostate cancer. 36 The calcifications may have a similar signal behavior as GFMs in T2w sequences, i.e., a signal void. 25, 37, 38 The same signal behavior may also be found from vessels in the prostate or post biopsy fibrosis and hemorrhages. 37, 39 It can therefore be challenging to differentiate GFMs in T2w FSE-based sequences (Fig. 1) .
The elimination of the manual task of identifying the GFMs in an MRI only workflow would be cost-effective and also eliminate the interobservatory differences and repeatability issues among human operators.
The feasibility of automatic GFM identification without the need for a dedicated identification sequence was demonstrated in T1-weighted images using a template matching approach where 67% of the patients (n = 15) had all markers correctly identified. By manual detection, 73% of the same patients had all markers correctly identified. The authors also concluded the need for improved differentiation between GFMs and intraprostatic calcifications. 37 Another method for automatic GFM identification were recently proposed utilizing a machine learning pattern recognition framework using image information from a Medical Physics, 44 (11), November 2017 multiparametric acquisition protocol containing five different MRI series. About 81% of the patients (n = 32) had all markers correctly identified. 40 Neither of the methods aimed at identifying the GFMs in the target sequence and image registration is therefore be inevitable. To remove the need for image registration or the need to account for possible within-session motion in MRI only workflows, we propose an alternative method.
The aim of this study was to: (a) develop a model for GFM identification and differentiation against intraprostatic calcifications, directly applied to the target delineation sequence without the need for image registration, (b) evaluate the developed model in an automated software for GFM identification, and (c) compare the performance of the automatic method against human observers.
MATERIALS AND METHODS
The proposed method relied on images from a clinical T2w target delineation FSE-and a clinical multiecho gradient echo (MEGRE)-based sequence. These kinds of acquisition sequences are available on all MRI platforms. The methodology exploited the increased sensitivity to susceptibility effects resulting in increasing artifact size with increasing echo time (TE) in a MEGRE-based MRI sequence (Fig. 2) . Gold fiducial marker candidates were automatically determined in the T2w MR images and mapped to an approximate position in the MEGRE images. All further analyses were performed in the MEGRE images (Fig. 3) . The final GFM candidates were determined in the T2w image geometry.
2.A. GFM identification
A model for automatic identification and differentiation of GFM candidates in transversal T2w MR images intended for prostate target delineation was developed in MATLAB (version R2016a; Mathworks Inc., Sherborn, MA, USA). The model used a training dataset to identify GFM candidates by cross-correlating image data from multiple MRI sequences. The values of the model parameters was, unless stated otherwise, optimized in an iterative way using the training data. For an overview of the model workflow, see Fig. 3 . To evaluate the performance, the model was applied to a second dataset, referred to as validation data. A human observatory study was also conducted on the second dataset to investigate the performance of manual GFM identification.
2.A.1. Patient preparation and data acquisition
The study was approved by the regional ethics board "Regionala Etikpr€ ovningsn€ amnden in Lund" with diary In the validation dataset, 44 consecutive prostate cancer patients without hip prosthesis undergoing primary EBRT were included. Mean weight for the validation dataset (n = 44) was 86. 3. An overview of the model workflow. The T2w propeller data (a) were segmented using the clinical target volume (CTV) (b) and were binarized for multiple thresholds (c). Gold fiducial marker (GFM) candidates were determined from the connected binary voxels (d). The multiecho gradient echo (MEGRE) data were binarized (e) and the GFM markers were transferred (f). The positions of the GFM candidates in the binarized MEGRE images individually defined starting points for a region grow segmentation, performed for all TEs (g). Candidate discrimination criteria were applied in a given order (h, step [1] [2] [3] [4] [5] [6] Each patient in the training and validation data was subject to the insertion of three inferior-superior long axis-oriented cylinder-shaped intraprostatic GFMs (length 5.0 mm and diameter 1.0 mm). The GFMs were inserted transrectally or perineally using a clinical routine by an oncologist 2 weeks prior to image acquisition. Vi-siblin â was administered once daily during 14 days prior to CT. Microlax â was administered 1 hour prior to CT. The CT and MRI examinations were performed by a predefined acquisition protocol and in direct connection to each other.
Three patients in the validation dataset had, due to GFM migration, only two GFMs remaining in the prostate at the time of image acquisition. Four patients were excluded from the validation data set due to major imaging artifacts stemming from large amount of rectum gas (Fig. 2) .
All MRI examinations were performed using a 3T wide bore 70 cm MRI system (Discovery 750W, Software DV25.0R02-1549b, General Electric Healthcare, Milwaukee, WI, USA) equipped with a flat table top. The MRI system was continuously being subject to monthly quality control using vendor-specific coil tests and a third party commercial phantom for assessing geometric accuracy for large field of views (Spectronic Medical AB, Helsingborg, Sweden). A GE GEM Anterior Array 16 channel receiver array coil was placed over the pelvic area of the patients using stiff coil bridges.
The clinical MRI sequence used for target delineation was a FSE-based T2w transversal MRI sequence, referred to as the target delineation sequence. The MRI sequence used for GFM identification was referred to as the MEGRE sequence. This multiecho sequence acquired gradient echo images for multiple slices for multiple TEs simultaneously. In this sequence, the shape from the signal void from the GFM was round, and the area increased with increasing TE. The artifact size was usually larger than the physical dimensions of the GFM and spanned through multiple slices. The image dataset was referred to as MEGRE data. To minimize motion between the sequences, the MEGRE sequence was executed either immediately before or after the target delineation sequence. All image data had automatic vendor-based image homogenization applied to it. Parameters for MRI sequences are displayed in Table I .
All CT examinations were acquired with a Siemens Somatom Definition AS+ (Siemens Healthcare, Forchheim, Germany, slice thickness 3 mm, reconstructed diameter 500 mm and reconstructed in-plane resolution 0.98 mm 9 0.98 mm).
2.A.2. GFM candidate detection in the T2w image
Using the automated software for GFM identification, a set of potential GFMs, referred to as GFM candidates, were detected in the T2w target delineation sequence. The GFMs did not generate any MR signal and was visualized as signal void voxels. Other objects in the prostate, such as intraprostatic calcifications or post biopsy hemorrhage had similar signal behavior and could not be differentiated from each other. All of these objects were therefore identified as GFM candidates.
The clinical target volume (CTV) from the treatment plan of the patient was used as a rough mask to limit the number of candidates detected in the automated software. The segmented T2w image was normalized to the maximum signal value and in a loop binarized using threshold values of 0% to 15% (step size of 1%) of the maximum signal value. In each step, the 3D connected components with a value of 1 and a connectivity of at least 6 voxels were identified and the coordinates for the center of mass (COM) of the 3D connected components were determined. If the coordinates for COM of a current candidate were within a radius of 2 mm of a previous detected candidate, the current candidate was discarded. This implicated that candidates detected for lower threshold values (therefore lower signal) were prioritized over candidates detected for higher threshold values.
A set of reference GFMs coordinates were defined manually as a data preparation step by an experienced physicist using all the available image information from MRI and CT. One fake GFM candidate in each patient was automatically inserted in the software to assess the performance of discriminating true negative candidates. The fake GFM candidate was assigned coordinates that equaled the average position of the specific patient reference GFMs coordinates. Vendor-specific name of the sequence used was a multiecho FGRE. Medical Physics, 44 (11), November 2017
2.A.3. GFM identification and image processing in the MEGRE images
Image information from the MEGRE sequence was used to determine which of the GFM candidates corresponded to the true GFMs. The MEGRE data volume was interpolated in all spatial directions with a factor of 2 (to 1024 9 1024 9 64) and every slice for each echo was binarized using a locally 2D adaptive threshold method. 41 Zero-valued pixel clusters of < 150 pixels in the binarized MEGRE slices were replaced with the value 1. The coordinates for the COM of the GFM candidates in the T2w images were converted to the corresponding coordinates in the binarized MEGRE data, using the DICOM MRI coordinate system. A GFM candidate was classified as potentially true if its position in the binarized MEGRE data correlated to a round area of zero-valued pixels and the round area was increasing with increasing TE.
2.A.4. GFM candidate discrimination
The GFM candidates in the binarized MEGRE data were defined as the starting points for separate region grow segmentations. The region grow segmentation was done independently for each echo in the binarized MEGRE data. A collection of discrimination criteria were applied in a given order to determine which GFM candidates corresponded to the true GFMs (Fig. 3) .
Region grow segmentations which produced an area larger than 1/30 of the largest prostate slice CTV segmentation was discarded to avoid over segmentations. This was referred to as step 1 discrimination. The area and roundness for each region grow segmentation for each TE after segmentation area discrimination were calculated. The roundness was defined as
where R was a measure for roundness ranging from 0 to 1 where 1 equaled a perfect circle, S A being the area of the region grow segmentation and S P being the perimeter of the region grow segmentation. The mean value for the roundness, calculated using all echoes, was used in the automated software as the measure for roundness.
The magnetic susceptibility difference between the GFM and the surrounding tissues created inhomogeneities and micro-gradients in the static magnetic field. Due to the absence of a spin refocusing pulse in the MEGRE sequence, the origin of the artifact was dominated by the effect of intravoxel spin dephasing. The phase change within a voxel can be described as
where c is the gyromagnetic ratio, G i is the internal magnetic field micro-gradient, Dr is the voxel size and TE is the echo time. 42 The intravoxel phase change increases with increasing echo time, resulting in an echo time-dependent decreasing MRI signal which created the signal voids.
The GFM was assumed to have the largest magnitude of susceptibility for all available tissues in the prostate. 17 The change in the region grow segmentation area with respect to the TE was assumed to be linear and dependent on the susceptibility. 18, 43 The linear change was referred to as the area slope and was calculated in the automated software by fitting a first-degree polynomial to the area and TE data.
The lower limits of roundness and area slope were applied in the respective order to the GFM candidates with a value of 0.67 and 10 pixels/ms (in interpolated binarized MEGRE data). This was respectively referred to as step 2 and step 3 discrimination. The lower limit of roundness was chosen to allow for a nonperfect round shape, allowing inclusion of tilted GFMs. The lower limit of area slope was chosen to allow for nonperfect segmentation of each individual TE.
Multiple GFM candidates corresponding to the same signal void and within a radius of 6 mm in the binarized MEGRE echo 6 data were referred to as sibling candidates. All GFM sibling candidates except the sibling candidate closest to the COM of the signal void was discriminated. This was referred to as step 4 discrimination. Further discrimination was performed by excluding the candidates that did not have a signal void for the lowest TE in the MEGRE images, referred to as step 5 discrimination.
If more than three candidates remained, the three GFM candidates with the largest roundness were considered to be the final GFM candidates, referred to as step 6 discrimination. The final GFM candidates that were within a radius of 7.5 mm to the reference GFMs coordinates in the T2w image were considered the true GFMs. The value of 7.5 mm was selected to encompass the length of the cylinder-shaped GFM (5.0 mm), taking into account the potential partial volume artifact in slice direction and to allow for a minor positioning error when defining the reference GFMs coordinates.
2.B. Analysis of the detection performance of the model
The detection performance of the developed model was assessed using the common detection performance metrics sensitivity = TP/(TP + FN), specificity = TN/(TN + FP), accuracy = (TN + TP)/(TN + TP + FN + FP) where TP, true-positive GFM candidate; TN, true-negative GFM candidate; FP, false-positive GFM candidate; FN, false-negative GFM candidate. For comparison with previous studies, the true-positive rate (TPR) was defined as TP/(total of all GFM in the study) which is equal to the sensitivity metric.
2.C. Analysis of the GFM spatial position
The true gold maker fiducial positions were determined in the CT using an automatic method. The CT volume was segmented using the CTV as a segmentation mask, normalized and then binarized using Otsu's segmentation method. 44 The 3D connected components with a value of 1 and a connectivity of 26 voxels were identified and the coordinates for the Medical Physics, 44 (11), November 2017 COM of these 3D connected components were determined. The COM of the 3D connected components was checked for validity and considered to be the true GFM positions. The spatial position of the final GFM candidates in the MR images of the target delineation sequence remaining after the discrimination steps were compared with the true GFM positions defined in the CT images. The most caudal true GFM and final GFM candidate was defined as M 1 . The most cranial one was defined M 3 and the intermediate was defined M 2 . The internal distances between all the true-positive GFM candidates detected in the MRI and true GFMs in the CT was calculated using the respective distances M 2 À M 1 , M 3 À M 1 , and M 3 À M 2 . The difference in the GFM internal distances between CT and MRI were calculated by
2.D. Human observatory study of GFM detectability
A manual human observatory study was conducted to compare the performance of the automatic method against the performance of five human observers. Three medical physicists and two MRI technologists were asked to delineate the GFMs in the T2w images. One of the medical physicists had seen the patient material 6 months prior to the observatory study. One of the MRI technologists did not comply with given instructions and was excluded. The observers were presented with the T2w and the MEGRE images simultaneously in an in-house developed MATLAB graphical user interface. The detection performance and analysis of the GFM spatial position was assessed using the same criterions as in the automatic method. To enable the comparison, a value for truenegative GFM was set to 1 for each patient.
RESULTS
The number of true GFMs, detection of calcification, and number of GFM candidates remaining after each discrimination step together with the detection performance of the model for each patient in the validation data are displayed in Table II . Ten out of the 20, and 29 out of the 40 patients had intraprostatic calcifications ≥ 2 mm (FWHM) visible in the CT images for the training-and validation data, respectively.
Ninety eight GFMs out of 117 true GFMs were correctly identified and considered true positive. This corresponded to a TPR of 84%. The missing 19 GFMs were considered false negative. Fourteen GFMs were falsely identified as true GFMs and considered false positive. The fake candidate inserted for each patient were successfully discriminated yielding a total true negative of 40 GFMs. Using TP = 98, FN = 19, FP = 14, and TN = 40 yielded sensitivity = 84%, specificity = 74%, and accuracy = 81%.
All true GFMs were correctly identified in 24/40 patients (=60%). Out of those 24 patients, two patients had only two GFMs left in the prostate due to GFM migration and 15 patients had detected calcifications ≥ 2 mm (FWHM).
Thirteen out of the 14 false-positive GFMs candidates were due to calcifications mistaken for GFMs. One out of 14 falsepositive was due to a signal void in the MEGRE of unknown origin. Two out of the 19 false-negative GFMs candidates were due to the absence of a GFM candidate, 3 out of the 19 did not have a roundness above the lower limit, and 6 out of the 19 did not have an area slope above the lower limit or had an incorrectly calculated area slope due to a failed segmentations. Eight out of 19 was excluded in discrimination step 6.
The mean, standard deviation, minimum and maximum absolute difference in the internal distances of the true-positive GFM candidates between CT and MRI for the 40 included patients is displayed in Table III .
The mean detection performance for the manual observatory study was 98 AE 1 [97 100]%, 94 AE 4 [92 100]%, 97 AE 2 [96 100]% for sensitivity, specificity, and accuracy, respectively. The mean TPR was determined to be 98 AE 1 [97 100]%. The mean number of patients with all GFMs correctly identified was 41.5 out of 44. The mean absolute difference in the internal distances between the true-positive GFM candidates and true GFMs in the CT, measured for all truepositive candidates in all patients and all observers, was 1.14 AE 1.06 [0.01 6.26 mm].
DISCUSSION
This study developed a method for automatic detection of intraprostate GFMs in T2w target delineation MR images. The method relied on transformation of image information from MEGRE images acquired at multiple TEs to the T2w images without any need for image registration. The T2w images presented the GFMs as small signal voids. The proposed method increased the signal void volume of the GFMs with respect to TE to separate the GFMs from other potential signal voids in prostate.
The method was validated for 40 prostate cancer patients. The sensitivity, specificity, and accuracy of the automatic GFM detection were 84%, 74%, and 81%, respectively. The mean absolute difference in the GFM internal distances between CT and MRI was shown to be 1.28 AE 1.25 mm. The same patient image material was used for the manual human observatory study with four observers where the sensitivity, specificity, and accuracy was determined to be 98%, 94%, and 97%, respectively. The mean absolute difference in the GFM internal distances between CT and MRI was shown to be 1.14 AE 1.06 mm.
The experiments suggest that acquiring MEGRE images could be a valid approach in identifying GFMs, both for automatic and manual detection methods. In analogy to the calculated area slope and roundness in the automatic method, these image features can easily be recognized by a human eye and thereby enable identification and discrimination of GFMs.
Previous studies regarding automatic identification of GFMs have used image registration for GFM detection and calculation of model accuracy. 37, 40 One of these studies used
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GRE-based MRI sequences to produce T1-and T2*-weighted images. The sensitivity, specificity, and accuracy for the T1-weighted images were 0.84, 1, and 0.88 and for the T2*-weighted images, it were 0.55, 0.86, and 0.63. The model accuracy was determined to be 0.5 AE 0.5 mm for both image types. 37 Another study using multiparametric MRI information yielded a TPR of 0.95. The balanced steady-state free precession sequence (bTFE) was recommended to improve the GFM detection and performed alone a TPR of 0.77. The model accuracy was respectively determined to be 1.6 mm and 1.7 mm for multiparametric and bTFE MRI information. 40 TABLE II. Number of GFM candidates left after each discrimination step and the detection performance of the model for all patients in the study. Detected calcifications ≥ 2 mm (FWHM) and number of true GFMs in the CT for each patient in the study are shown. Patient 6, 20, 22 , and 30 were excluded from the study due to major imaging artifacts stemming from large amount of rectum gas.
However, due to the possibility of prostate motion between MRI and CT, image registration was avoided in our study. To assess the model accuracy, the mean absolute difference in the internal distances of the true-positive GFMs between CT and MRI was calculated. With respect to the difference in slice thickness used for the image acquisition in previous studies, our results for the GFMs spatial position were similar. 37, 40 The TPR of our method was determined to be 84% which was larger than the TPR for the bTFE alone but smaller than the TPR determined for multiparametric MRI. 40 The detection performance results from the human observatory study showed that MEGRE images could be a valid approach for identifying GFMs. The mean absolute difference in the internal distances of the true-positive GFMs between CT and MRI determined in the observatory study was similar to the results of previous manual detection studies reporting 0.6 AE 0.4 and 0.6 AE 0.6 mm. 25, 37 Multiecho gradient echo with sum of squares echo combination for echo averaging has previously been shown to enhance detection of 125-Iodine seeds and GFM. It was concluded that multiple echoes for GRE provided better detection performance than both conventional FSE and single echo GRE. 22 In our study MEGRE was used without echo combination. Previous study states that the presence of air pockets such as rectal gas could obstruct the GFM detection using bTFE. 40 The use of image data acquired at multiple TEs for manual GFM detection can be beneficial for patients with rectal gas induced artifacts as these artifacts are mitigated for lower TEs (Fig. 2) . By the same principle this could benefit patients with metallic hip prosthesis. Furthermore, by not doing echo averaging the image features, such as area increase with increasing TE, can remain unimpaired and recognized by a human eye.
The increasing area of the GFM signal void with respect to increasing TE in our work was due to the large difference in magnetic susceptibility between the GFM and surrounding tissue combined with a larger effect from T2* relaxation for larger TEs.
Due to the remaining variety of image contrast, noise and artifacts among the patient data after MRI vendor-based image homogenization (SCIC, Table I), the use of an adaptive segmentation method 41 was crucial. For the purpose of this work, the adaptive segmentation method was superior compared to a global thresholding method. 44 An accurate automatic segmentation of the signal void area was crucial for calculating a representative area slope and roundness. The actions above were not always sufficient to accomplish this for all echoes. This contributed to an error in the calculation of roundness and area slope, leading to an increase in falsenegative candidate count.
If the long axis of the GFM marker is parallel with the B0 field and orthogonal with respect to the imaging plane, the signal void artifact in the MEGRE images would be round in its shape. A scenario with deviations from these prerequisites would lead to a change in artifact shape. 17 Exclusions due to such a scenario was avoided by setting the lower limit for roundness to no more than 0.67. In three cases, the GFM candidate was not classified as round enough. This was most probable due to incorrect segmentation of the signal void.
The fractions of patients with intraprostatic calcifications ≥ 2 mm (FWHM) in the training and validation data were 10/ 20 and 29/40, respectively. This is larger than the fraction of one-third previously reported for intraprostatic calcifications > 2 mm in diameter. 36 To reduce the number of false-positive GFM candidates, the existence of a signal void in the first echo of the MEGRE images, originating from the GFM candidate, was required (discrimination step 5). This was analogous to prioritizing objects with the largest magnetic susceptibility, i.e., the GFM.
The differentiation between GFM and other objects, such as intraprostatic calcification, relied on the assumption that the magnetic susceptibility, the area slope, and roundness were larger for GFMs. Previous studies support this assumption. 17, 18, 43 The pixelated nature of a digital image could affect the roundness calculation. The interpolation to 1024 9 1024 pixels in-plane was performed to reduce such potential calculation errors.
The developed method provided a way to identify the GFM without the use of image registration. The consecutive order of the target delineation and MEGRE sequence was of importance to avoid a large patient displacement between the scans. The assumption of an unchanged frame of reference, i.e., patient or prostate displacement between the scans, might not always be true, but due to the larger extent of the signal voids in the MEGRE data for higher TEs, the method provided an intrinsic tolerance for some patient and prostate displacements. No cases of patient or prostate displacement were reported as an origin of failure in the method.
The exclusion of study patients due to large amounts of rectal gas could in the future be resolved by asking the patients to use a bowel relaxant agent prior to the examination to reduce bowel peristalsis. 45 Other means of mitigating the artifacts could be to increase the receiver bandwidth or change the direction of frequency encoding.
One of the motivations for developing an automatic method for GFM detection is the elimination of manual labor. The detection performance for the developed method, in terms of accuracy, did not reach 100%. The method could still provide valuable input in the prostate treatment planning process as it eliminates the need for image registration but at this stage visual inspection of the results is needed before proceeding to treatment.
TABLE III. The mean, standard deviation (SD), minimum (Min), and maximum (Max) absolute difference in the internal distances of the true-positive GFM candidates between CT and MRI. Number of measured distances (n) was dependent on the total amount of true-positive GFM candidates determined in total. With the prerequisite of signal voids from the GFM the proposed method could also be applied to large FOV images dedicated for synthetic CT generation. This is presently being used in an ongoing clinical study called MR-PROTECT (MR-Prostate RadiOTherapy Excluding CT) for MRI only radiotherapy for prostate at our clinic. If FSE technique has been used for acquiring large FOV images, it is of importance to notice that a longer echo train will give rise to increased image blurring, potentially concealing the small signal voids. 46 Partial volume effects can also conceal the small signal voids and care must therefore be taken when choosing the acquisition voxel size and the length of the echo train.
The number of false-positive GFM candidates in the target delineation images could be reduced by implementing a prior knowledge model of the GFM volume. The use of such a model has been demonstrated in a previous automatic method. 37 Other means of improving the detection accuracy of GFM could be by magnetic susceptibility mapping or by providing positive contrast in the vicinity of the marker using off-resonance signals. [29] [30] [31] [32] 47 As MEGRE is a generic and available sequence on multiple vendor platforms this should be further explored for both automatic and manual GFM identification.
CONCLUSIONS
This study developed an automatic method for identifying gold fiducial markers in an MRI target delineation image, without the need for image registration. The differentiation and identification of gold fiducial markers was based on a multiecho gradient echo MRI sequence which also showed good performance in a human observatory study. By using an automatic method, the manual workload can be reduced and several operator related sources of uncertainties can be eliminated or mitigated. For clinical practice, visual inspection of the results from the automatic method is needed at the current stage.
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